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ABSTRACT
An efficient one-pot synthesis of N-aryl[3,4-d]pyrazolopyrimidines in good yield and under mild reaction conditions is described. By exploiting
electron-deficient hydroxylamines, the substituted oxime products were formed with very high E-diastereoselectivity. The key step utilizes a
cyclization reaction upon an oxime derived from hydroxylamine-O-sulfonic acid to form the NN bond of the product.
The discovery of ATP-competitive inhibitors of protein
kinases and ATPases has become one of the most active
areas of research in medicinal chemistry and the pharma-
ceutical industry.
1 [3,4-d]Pyrazolopyrimidines are impor-
tant scaffolds in this respect because of their ability
to closely mimic the purine ring of adenosine in ATP
while imparting changes to the electronic properties of the
ring system and creating novel vectors for substitution.
The [3,4-d]pyrazolopyrimidine scaffold has been used in
potent inhibitors of various protein kinases and ATPases,
which has led to a greater understanding of the role of
these enzymes in disease and to the development of novel
therapeutics.
2
An important factor in a successful drug discovery
program is the ability to synthesize a large number of
structural analogues in a rapid and efficient manner, in
order to establish structureactivity relationships and
modifyphysicochemicalpropertiesofcompounds.Anum-
ber of approaches to the synthesis of [3,4-d]pyrazolo-
pyrimidine libraries have previously been described which
focusedonthecyclizationofhydrazinederivativeswithan
appropriate electrophile to incorporate the NNb o n do f
the ring system.
3 However, utilizing hydrazines has a
number of disadvantages, including lengthy synthetic se-
quences,thesynthesisandhandlingofhydrazinederivatives,
low overall yields, and harsh reaction conditions. These
synthetic drawbacks have so far limited the application of
the pyrazolopyrimidine scaffold in medicinal chemistry.
During a recent project investigating the function of
chaperonin ATPases in cancer,
4 we required the rapid
synthesis of a library of ATP-mimics based on the [3,4-d]-
pyrazolopyrimidinescaffold.Toachievethis,wedeveloped
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a novel one-pot synthesis that is readily applicable to
producinganaloguesusingcommerciallyavailablestarting
materials and does not require metal-based catalysts or
hydrazines.
Rather than incorporating the NN bond of the aro-
matic heterocycle as a preformed unit prior to cyclization,
this functionality can be introduced in the key synthetic
step via a cyclization reaction using an appropriately
activated nitrogen source.
5 This approach negates the
requirement for the synthesis and handling of hydrazines
and exploits the greater number of commercially available
amine derivatives,expandingthe diversityof pyrazolopyr-
imidine libraries that could be used in drug discovery. A
related NN bond-forming cyclization reaction was pre-
viously observed by Fenniri and co-workers during their
attemptedsyn-eliminationofanE-oximederivativetogive
an i t r i l e .
6 The undesired pyrazolopyrimidine byproduct
was isolated in 28% yield.
We began our synthesis with a nucleophilic substitution
reactiononthecommerciallyavailabledichloropyrimidine
aldehyde 1 with aniline to give 2 in 96% yield under
standard conditions (Scheme 1).
7 No products resulting
from imine formation at the aldehyde functionality were
observed.Theresultingpyrimidine2wasthentreatedwith
hydroxylamine hydrochloride in ethanol to give oximes 3
and 4 as a 1:1 mixture of E-a n dZ-isomers.
8 Owing to
decomposition during attempted chromatographic separa-
tion, the mixture was taken on to the next step without
further purification.
9 Treatment of oximes 3 and 4 with
mesyl chloride and N,N-diisopropylethylamine gave the
desired pyrazolopyrimidine 6 in 41% isolated yield. It has
previously been reported that only E-oximes can undergo
NNbond-formingcyclizationswithaminestogive5-mem-
bered aromatic rings.
10 The nitrile byproduct 5 was isolated
in 36% yield, presumably as a result of elimination of the O-
mesyl-Z-oxime isomer intermediate, since this isomer could
not undergo cyclization to form the desired product.
11
Toimprovetheoverallyieldofthecyclizationstrategyit
was necessary to synthesize the E-oxime 3 with high
diastereoselectivity. The stereoselectivity of oxime forma-
tioncanbedifficulttocontrolforaromaticaldehydes,with
results often depending on catalyst and temperature.
12
However, in this case, changes to the reaction conditions
gave little improvement in diastereoselectivity of this reac-
tion. It had previously been proposed that E-oxime dia-
stereoselectivitycouldbeimprovedbyincreasingthesteric
hindranceoftheO-substituentonthehydroxylamine.
13To
investigate this rationale, a number of oxime derivatives
weregeneratedusingsubstitutedhydroxylamines(Table1).
Scheme 1. Stepwise Pyrazolopyrimidine Synthesis
Table 1. Substituted Hydroxylamines
entry hydroxylamine E:Z ratio
b
1N H 2OH3HCl 1:1
2N H 2OBn3HCl 1:1
3N H 2Ot-Bu3HCl 2:3
4N H 2OTMS
a 4:1
aProduct observed as free oxime.
bDetermined by examination of
crude
1H NMR spectrum.
Scheme 2. Oxime Stereoselectivity
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It was clear from our screen that the diastereoselectivity
of oxime formation was not determined by the relative
steric hindrance of the O-hydroxylamine substituent. In-
creasing steric hindrance from hydroxylamine to O-tert-
butylhydroxylamineactuallyresultedinasmallpreference
for the formation of the Z-diastereomer.
14 In contrast,
O-TMS-hydroxylaminegaveincreaseddiastereoselectivity
for the desired E-oxime isomer. To explain the observed
stereoselectivity, we proposed that the electron-withdrawing
nature of the siliconsubstituent in O-TMS-hydroxylamine
15
slowed the stereodefining elimination step of oxime forma-
tion (Scheme 2). This allowed intermediate 7to rearrange to
t h em o r es t a b l ec o n f o r m e r8, which contains an intramolec-
ular NHN-hydrogen bond and the OR group in a pseudoe-
quatorial conformation.
16 Conformational change prior to
elimination forces the hydroxylamine derivative away from
the aromatic ring so that the elimination step occurs with
high E-stereoselectivity.
We were able to exploit this observation by utilizing the
commercially available hydroxylamine-O-sulfonic acid as
anelectron-deficienthydroxylamineequivalent.Treatment
of aldehyde 2 with hydroxylamine-O-sulfonic acid in etha-
nolresultedintheformationofE-oxime3,in87%yieldand
>9:1 dr (Scheme 1).
17 The intermediate O-sulfonic acid
oxime was not observed, presumably due to ethanolysis
under the reaction conditions. Reaction of E-oxime 3 with
mesyl chloride and N,N-diisopropylethylamine resulted in
cleancyclizationtogivethedesiredpyrazolopyrimidine6in
74% yield (Scheme 1).
18
Hydroxylamine-O-sulfonic acid has previously been
exploitedasasourceofelectrophilicnitrogentosynthesize
NNa n dN O bonds.
19 Under our reaction conditions,
no spontaneous cyclization of the O-sulfonic acid oxime
intermediate 9 was observed. When the oxime synthesis
was carried out in acetonitrile, intermediate 9 was suffi-
ciently stable to be observed by
1H NMR spectroscopy,
confirmingthehighdiastereoselectivityofthereaction(the
minor isomer couldnot beobservedby
1H NMR analysis,
see the Supporting Information). Unfortunately, treat-
ment of intermediate 9 under both acidic and basic condi-
tionsinvariousorganicsolventseitherledtosyn-elimination
to give nitrile 5 or a complex mixture of products through
decomposition.
In Kemp and Woodward’s seminal publication on the
use of hydroxylamine-O-sulfonic acid for the synthesis of
benzisoxazole, biphasic reaction conditions were em-
ployed to facilitate the cyclization reaction.
20 Presumably,
aqueous conditions stabilize the highly charged sulfonate
leaving group, promoting the cyclization process. A solu-
tion of intermediate 9 in acetonitrile was therefore diluted
withdichloromethaneandaqueous1Msodiumhydroxide
solution. Clean cyclization proceeded to give the desired
pyrazolopyrimidine 6 in 59% yield from 2, and no nitrile
byproduct 5 was observed. Finally, we were able to
combine all three steps of this synthesis into a one-pot
procedure by carrying out the nucleophilic substitution
reaction of 1 with aniline in acetonitrile. Hydroxylamine-
O-sulfonic acid was then added followed by dilution with
dichloromethane and aqueous 1 M sodium hydroxide
solution to give a biphasic mixture, which resulted in the
formation of the desired pyrazolopyrimidine 6 in 51%
yield from 1 (Scheme 3).
Toexplorethescopeofourone-potpyrazolopyrimidine
synthesis, several analogues were synthesized incorporat-
ing both electron-donating and -withdrawing groups
on the aromatic ring (Table 2). The targets were produced
in good yield from this three-step, one-pot protocol.
Of note are the mild reaction conditions used which allow
for potentially sensitive functionality, labile protecting
groups, and unprotected groups to be used while still
affording good yields. Unfortunately, the use of aliphatic
amines failed to induce formation of the desired pyrazo-
lopyrimidine17,despitethesuccessofthefirsttwostepsof
this protocol.
21 Treatment of the O-sulfonic acid oxime
Scheme 3. One-Pot Synthesis
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intermediate derived from allylamine with base resulted
only in a complex mixture of products.
Although the mechanism of this unusual NN bond-
forming reaction is unclear, a plausable mechanism is
shown in Scheme 4.
22 This resembles the mechanism of
the Neber reaction used to synthesize indoles.
23 Af u r t h e r
discussion of possible mechanisms is presented in the
Supporting Information.
In summary, we have described a novel one-pot synth-
esisof N-aryl[3,4-d]pyrazolopyrimidines in good yield and
under mild reaction conditions. By exploiting electron-
deficient hydroxylamines the oxime product was formed
withveryhighE-diastereoselectivity.Thekeysteputilizesa
hydroxylamine-O-sulfonic acidderivedoxime ina cycliza-
tion reaction to form the NN bond of the pyrazolopyr-
imidine ring. Carrying out the reaction under biphasic
aqueous conditions promoted clean ring closure to afford
the pyrazolopyrimidines with a range of functionality in
goodyield.Webelieveourone-potprotocolisasignificant
additiontothemethodologiesavailableforthesynthesisof
these important pharmaceutical compounds.
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Scheme 4. Plausable Mechanism
Table 2. Three-Step One-Pot Pyrazolopyrimidine Synthesis
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